has been cited by the following article(s):
[1]
|
Identification of a Human Anti-Alpha-Toxin Monoclonal Antibody Against Staphylococcus aureus Infection
|
|
Frontiers in …,
2021 |
|
|
[2]
|
Nouvelles méthodes électrochimiques pour le criblage d'inhibiteurs de transcétolases
|
|
2018 |
|
|
[3]
|
Recent progress in the identification and development of anti-malarial agents using virtual screening based approaches
|
|
Combinatorial chemistry & high throughput screening,
2015 |
|
|
[4]
|
Chemical and genetic validation of thiamine utilization as an antimalarial drug target
|
|
Nature communications,
2013 |
|
|
[5]
|
Molecular Modelling and Docking Studies of Human Blood Coagulation Factor-XIIIA Protein
|
|
SK Gunda, AM Madasu, P Kakarla, M Shaik - ijrpbsonline.com,
2013 |
|
|
[6]
|
Synthesis of hybrid 4-anilinoquinoline triazines as potent antimalarial agents, their in silico modeling and bioevaluation as Plasmodium falciparum transketolase and β-hematin inhibitors
|
|
MedChemComm,
2012 |
|
|
[7]
|
Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets?
|
|
International journal of biological sciences,
2011 |
|
|
[1]
|
Identification of a Human Anti-Alpha-Toxin Monoclonal Antibody Against Staphylococcus aureus Infection
Frontiers in Microbiology,
2021
DOI:10.3389/fmicb.2021.692279
|
|
|
[2]
|
Innovative Electrochemical Screening Allows Transketolase Inhibitors to Be Identified
Analytical Chemistry,
2018
DOI:10.1021/acs.analchem.8b01752
|
|
|
[3]
|
Innovative Electrochemical Screening Allows Transketolase Inhibitors to Be Identified
Analytical Chemistry,
2018
DOI:10.1021/acs.analchem.8b01752
|
|
|
[4]
|
Chemical and genetic validation of thiamine utilization as an antimalarial drug target
Nature Communications,
2013
DOI:10.1038/ncomms3060
|
|
|
[5]
|
Chemical and genetic validation of thiamine utilization as an antimalarial drug target
Nature Communications,
2013
DOI:10.1038/ncomms3060
|
|
|
[6]
|
Synthesis of hybrid 4-anilinoquinoline triazines as potent antimalarial agents, their in silico modeling and bioevaluation as Plasmodium falciparumtransketolase and β-hematin inhibitors
Med. Chem. Commun.,
2012
DOI:10.1039/C1MD00188D
|
|
|